Showing results (461-470 of 1,129) with videos related to
Sort By:
Pageof 113
Best Practice & Research. Clinical Haematology|November 21, 2017
The evolving role of genomic testing in assessing prognosis of patients with myelodysplastic syndromesDavid P SteensmaBest Practice & Research. Clinical Haematology|November 21, 2017
Do cytogenetics affect the post-remission strategy for older patients with AML in CR1?James M ForanBest Practice & Research. Clinical Haematology|November 21, 2017
Which new agents will be incorporated into frontline therapy in acute myeloid leukemia?Richard M StoneBest Practice & Research. Clinical Haematology|November 21, 2017
Relapsed acute lymphoblastic leukemia: Is it crucial to achieve molecular remission prior to transplant?Mary EapenBest Practice & Research. Clinical Haematology|November 21, 2017
Cytokine release syndrome: Who is at risk and how to treatNoelle FreyBest Practice & Research. Clinical Haematology|October 21, 2017
How should we treat the AYA patient with newly diagnosed ALL?Nicolas BoisselBest Practice & Research. Clinical Haematology|December 14, 2022
Recent progress in acute leukemia and myelodysplasiaHetty E Carraway, Daniel A Pollyea, Eytan M SteinBest Practice & Research. Clinical Haematology|December 14, 2022
How can we intervene to mitigate post-transplantation relapse in AML? Strategies to mitigate post-transplantation relapse in AMLJonathan A GutmanBest Practice & Research. Clinical Haematology|December 6, 2020
The potential role of Bi-specific antibodies in acute myeloid leukemiaMusa Yilmaz, Farhad RavandiBest Practice & Research. Clinical Haematology|October 11, 2020
Molecular markers in ALL: Clinical implicationsShunsuke Kimura, Charles G MullighanPageof 113